9. Land Use Right

The land use right represents the land acquired for the purpose of constructing and operating the biologics manufacturing facility in Guangzhou. In 2017, the Company acquired the land use right from the local Bureau of Land and Resources in Guangzhou. The land use right is amortized over the total term of the right, which is 50 years. The land use right asset as of June 30, 2018 and December 31, 2017 is summarized as follows:


	As of
	June 30,	December 31,
	2018	2017
	$	$
Land use right, cost	12,422	12,633
Accumulated amortization	(290)	(168)
Land use right, net	12,132	12,465

Amortization expense of the land use right for the three and six months ended June 30, 2018 was $61 and $122, respectively. Amortization expense of the land use right for the three and six months ended June 30, 2017 was nil and nil, respectively.

As of June 30, 2018, expected amortization expense for the land use right was approximately $124 for the remainder of 2018, $248 in 2019, $248 in 2020, $248 in 2021, $248 in 2022 and $11,016 in 2023 and thereafter.